The global sickle cell anemia testing & screening market is anticipated to grow at a CAGR of around 6.2% during the forecast period 2021 to 2028 and to reach around US$ 337.9 Mn by 2028.
Market Dynamics
The total amount of hemoglobin S in a blood sample or mutations in the hemoglobin genes is measured by sickle cell. WHO estimates that more than 300,000 babies are born with sickle cell defects a year. Across Africa, sickle cell deficiency is known to be a significant inherited disease, with a prevalence of up to 45% across Uganda, for example. The occurrence is also observed in Nigeria, Cameroon, Ghana, Gabon and the Republic of Congo between 20 and 30 percent. There are so many research kits used for sickle cell monitoring including BIOMEDOMICS INC. Sickle SCAN, Streck Laboratories Performance Screening Kit, etc. The NHLBI (National Heart, Lung, and Blood Institute) is the third largest Laboratory of the NIH (National Institutes of Health) and is primarily engaged in the prevention and diagnosis of sickle cell disorders. Some groups are still involved in sickle cell research and diagnostics in the U.S. Sickle cell research is a form of clinical blood test to measure the existence of hemoglobin S, such as the Sickle Cell Disease Association of America (SCDAA). The prices of sickle cell treatment are relatively manageable, and the price range ranges from $2 to $30. Such methods are also used for sickle cell monitoring such as HPC, hemoglobin electrophoresis, or DNA experiments to figure out whether irregular hemoglobin is in the blood of a human. Nevertheless, it is highly necessary to take sickle cell screening before or after birth to reduce the possibility of sickle cell genetic disorders.
Many policy programs to promote the treatment of sickle cell anemia are projected to fuel the increase in sales on the global market for detecting & screening sickle cell anemia.
The success of pilot newborn research projects around countries with sickle cell anemia (Kenya, Congo, Ghana, etc.) drives each government to implement more measures that are expected to fuel the sales growth of this global market in the coming years.
The creation of portable, non-invasive imaging devices for the identification of sickle cell disease seeks to address barriers to the diagnosis and treatment of sickle cell anemia. Market players focus on developing point-of -care testing by means of cost-effective, compact, highly responsive methods such as densitometry, lateral flow immunoassay, micro-fluidic electrophoresis, etc.
Segment Analysis by Region
North America retained highest market share in 2020 and is expected to dominate the world's target market. Newborn screening services are implemented in 50 states in the United States and 8 provinces in Canada that has created an atmosphere conducive to businesses involved in the industry. Neonatal screening services have been well developed in developing regions such as Africa and Asia for the development and introduction of sickle cell disease. In areas where the disease's prevalence rate is 0.05% or higher, Sickle cell screening is generally recommended. Such screening systems provide a routine or tailored check for all newborns with hemoglobin C or sickle cell characteristics. At present, only few countries have adopted newborn screening program, owing to the shortage of appropriate infrastructure for the introduction of newborn screening programs. Recently, increasing awareness and acceptance of sickle cell screening aimed at newborns have been seen in Asia-Pacific countries, especially India. However, these developed countries are implementing approaches to tackle prenatal screening issues in high-income nations, and to streamline follow-up monitoring or diagnosis. It would offer the Asia Pacific industry a big boost in the near future.
COVID-19 Impact
Pandemic situation across the globe has disrupted the business flow worldwide. In 2020 every industry vertical in its 2nd, 3rd, 4th quarter has witnessed substantial drop on production and revenue, this was majorly due to lockdown. The restriction on the operations is impacting the production side and also impacting the supply chain of products. The disrupted supply of raw materials and low operational factories efficiency has contributed in the slower growth of the global market. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process at high operational efficiency, better supply chain models, and effective distribution network. These factors to some extent will help the industry vertical to flourish and aid market growth.
Competitive Landscape
The global market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
The global sickle cell anemia testing & screening market is segmented into technology, age group, and sector. The age group segment is bifurcated into Adult Screening (25 to 60 years), Newborn Screening (12 months and below), and Other Age Groups (1 to 25 & above 60 years). Among age group the Other Age Groups (1 to 25 & above 60 years) segment is expected to account for noticeable revenue share in the global market. The players profiled in the report Quest Diagnostics, BioMedomics Inc., STRECK, Silver Lake Research Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., HEMEX HEALTH, Bio-Rad Laboratories, and Others.
Market Segmentation
Sickle Cell Anemia Testing & Screening Market By Technology
High-performance Liquid Chromatography
Hemoglobin Electrophoresis
Isoelectric focusing
Paper-Based Rapid Diagnostics
Lateral Flow Immunoassay
Point-of-Care Tests
Others
Sickle Cell Anemia Testing & Screening Market By Age
Adult Screening (25 to 60 years)
Newborn Screening (12 months and below)
Other Age Groups (1 to 25 & above 60 years)
Sickle Cell Anemia Testing & Screening Market By Sector
Private Labs
Government Labs
Corporate Labs
PPP
Market By Geography
North America
• U.S.
• Canada
Europe
• U.K.
• Germany
• France
• Spain
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
CHAPTER 1.Industry Overview of Sickle Cell Anemia Testing & Screening
1.1.Definition and Scope
1.1.1.Definition of Sickle Cell Anemia Testing & Screening
1.1.2.Market Segmentation
1.1.3.Years Considered for the Study
1.1.4.Assumptions and Acronyms Used
1.1.4.1.Market Assumptions and Market Forecast
1.1.4.2.Acronyms Used in Global Sickle Cell Anemia Testing & Screening Market
1.2.Summary
1.2.1.Executive Summary
1.2.2.Sickle Cell Anemia Testing & Screening Market By Sector
1.2.3.Sickle Cell Anemia Testing & Screening Market By Age
1.2.4.Sickle Cell Anemia Testing & Screening Market By Technology
1.2.5.Sickle Cell Anemia Testing & Screening Market by Regions
CHAPTER 2.Research Approach
2.1.Methodology
2.1.1.Research Programs
2.1.2.Market Size Estimation
2.1.3.Market Breakdown and Data Triangulation
2.2.Data Source
2.2.1.Secondary Sources
2.2.2.Primary Sources
CHAPTER 3.Market Dynamics And Competition Analysis
3.1.Market Drivers
3.1.1.Driver 1
3.1.2.Driver 2
3.2.Restraints and Challenges
3.2.1.Restrain 1
3.2.2.Restrain 2
3.3.Growth Opportunities
3.3.1.Opportunity 1
3.3.2.Opportunity 2
3.4.Porter’s Five Forces Analysis
3.4.1.Bargaining Power of Suppliers
3.4.2.Bargaining Power of Buyers
3.4.3.Threat of Substitute
3.4.4.Threat of New Entrants
3.4.5.Degree of Competition
3.5.Market Concentration Ratio and Market Maturity Analysis of Sickle Cell Anemia Testing & Screening Market
3.5.1.Go To Market Strategy
3.5.1.1.Introduction
3.5.1.2.Growth
3.5.1.3.Maturity
3.5.1.4.Saturation
3.5.1.5.Possible Development
3.6.Technological Roadmap for Sickle Cell Anemia Testing & Screening Market
3.7.Value Chain Analysis
3.7.1.List of Key Manufacturers
3.7.2.List of Customers
3.7.3.Level of Integration
3.8.Cost Structure Analysis
3.8.1.Price Trend of Key Raw Materials
3.8.2.Raw Material Suppliers
3.8.3.Proportion of Manufacturing Cost Structure
3.8.3.1.Raw Material
3.8.3.2.Labor Cost
3.8.3.3.Manufacturing Expense
3.9.Regulatory Compliance
3.10.Competitive Landscape, 2020
3.10.1.Player Positioning Analysis
3.10.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Manufacturing Plant Analysis
4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020
4.2.R&D Status and Application Source of Sickle Cell Anemia Testing & Screening Major Manufacturers in 2020
CHAPTER 5.Sickle Cell Anemia Testing & Screening Market By Sector
5.1.Introduction
5.2.Sickle Cell Anemia Testing & Screening Revenue By Sector
5.2.1.Sickle Cell Anemia Testing & Screening Revenue (US$ Mn) and Forecast, By Sector, 2017-2028
5.2.2.Private Labs
5.2.2.1.Private Labs Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.Government Labs
5.2.3.1.Government Labs Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.4.Corporate Labs
5.2.4.1.Corporate Labs Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.5.PPP
5.2.5.1.PPP Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 6.Sickle Cell Anemia Testing & Screening Market Revenue By Age
6.1.Introduction
6.2.Sickle Cell Anemia Testing & Screening Revenue (US$ Mn) By Age
6.2.1.Sickle Cell Anemia Testing & Screening Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
6.2.2.Adult Screening (25 to 60 years)
6.2.2.1.Adult Screening (25 to 60 years) Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3.Newborn Screening (12 months and below)
6.2.3.1.Newborn Screening (12 months and below) Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.4.Other Age Groups (1 to 25 & above 60 years)
6.2.4.1.Other Age Groups (1 to 25 & above 60 years) Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 7.Sickle Cell Anemia Testing & Screening Market By Technology
7.1.Introduction
7.2.Sickle Cell Anemia Testing & Screening Revenue (US$ Mn) By Technology
7.2.1.Sickle Cell Anemia Testing & Screening Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
7.2.2.High-performance Liquid Chromatography
7.2.2.1.High-performance Liquid Chromatography Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.3.Hemoglobin Electrophoresis
7.2.3.1.Hemoglobin Electrophoresis Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.4.Isoelectric focusing
7.2.4.1.Isoelectric focusing Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.5.Point-of-Care Tests
7.2.5.1.Point-of-Care Tests Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.6.Others
7.2.6.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 8.North America Sickle Cell Anemia Testing & Screening Market By Country
8.1.North America Sickle Cell Anemia Testing & Screening Overview
8.2.U.S.
8.2.1.U.S. Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017-2028
8.2.2.U.S. Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017-2028
8.2.3.U.S. Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
8.3.Canada
8.3.1.Canada Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017-2028
8.3.2.Canada Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017-2028
8.3.3.Canada Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
8.4.North America PEST Analysis
CHAPTER 9.Europe Sickle Cell Anemia Testing & Screening Market By Country
9.1.Europe Sickle Cell Anemia Testing & Screening Market Overview
9.2.U.K.
9.2.1.U.K. Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017-2028
9.2.2.U.K. Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017-2028
9.2.3.U.K. Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
9.3.Germany
9.3.1.Germany Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017-2028
9.3.2.Germany Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017-2028
9.3.3.Germany Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
9.4.France
9.4.1.France Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017-2028
9.4.2.France Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017-2028
9.4.3.France Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
9.5.Spain
9.5.1.Spain Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017-2028
9.5.2.Spain Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017-2028
9.5.3.Spain Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
9.6.Rest of Europe
9.6.1.Rest of Europe Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017-2028
9.6.2.Rest of Europe Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017-2028
9.6.3.Rest of Europe Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
9.7.Europe PEST Analysis
CHAPTER 10.Asia Pacific Sickle Cell Anemia Testing & Screening Market By Country
10.1.Asia Pacific Sickle Cell Anemia Testing & Screening Market Overview
10.2.China
10.2.1.China Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
10.2.2.China Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
10.2.3.China Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.3.Japan
10.3.1.Japan Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
10.3.2.Japan Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
10.3.3.Japan Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.4.India
10.4.1.India Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
10.4.2.India Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
10.4.3.India Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.5.Australia
10.5.1.Australia Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
10.5.2.Australia Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
10.5.3.Australia Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.6.South Korea
10.6.1.South Korea Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
10.6.2.South Korea Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
10.6.3.South Korea Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.7.Rest of Asia-Pacific
10.7.1.Rest of Asia-Pacific Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
10.7.2.Rest of Asia-Pacific Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
10.7.3.Rest of Asia-Pacific Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
10.8.Asia Pacific PEST Analysis
CHAPTER 11.Latin America Sickle Cell Anemia Testing & Screening Market By Country
11.1.Latin America Sickle Cell Anemia Testing & Screening Market Overview
11.2.Brazil
11.2.1.Brazil Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
11.2.2.Brazil Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
11.2.3.Brazil Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
11.3.Mexico
11.3.1.Mexico Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
11.3.2.Mexico Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
11.3.3.Mexico Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
11.4.Rest of Latin America
11.4.1.Rest of Latin America Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
11.4.2.Rest of Latin America Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2016 – 2027
11.4.3.Rest of Latin America Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
CHAPTER 12.Middle East & Africa Sickle Cell Anemia Testing & Screening Market By Country
12.1.Middle East & Africa Sickle Cell Anemia Testing & Screening Market Overview
12.2.Saudi Arabia
12.2.1.Saudi Arabia Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
12.2.2.Saudi Arabia Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
12.2.3.Saudi Arabia Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
12.3.UAE
12.3.1.UAE Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
12.3.2.UAE Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
12.3.3.UAE Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
12.4.Rest of Middle East & Africa
12.4.1.Rest of Middle East & Africa Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Sector, 2017 - 2028
12.4.2.Rest of Middle East & Africa Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Age, 2017 - 2028
12.4.3.Rest of Middle East & Africa Sickle Cell Anemia Testing & Screening Market Revenue (US$ Mn) and Forecast By Technology, 2017 - 2028
CHAPTER 13.Player Analysis Of Sickle Cell Anemia Testing & Screening
13.1.Sickle Cell Anemia Testing & Screening Market Company Share Analysis
13.2.Competition Matrix
13.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2.New Product Launches and Product Enhancements
13.2.3.Mergers And Acquisition In Global Sickle Cell Anemia Testing & Screening Market
13.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14.COMPANY PROFILE
14.1.Eisenmann AG
14.1.1.Company Snapshot
14.1.2.Business Overview
14.1.3.Financial Overview
14.1.3.1.Revenue (US$ Mn), 2020
14.1.3.2.Eisenmann AG 2020 Sickle Cell Anemia Testing & Screening Business Regional Distribution
14.1.4.Product/ Service and Specification
14.1.5.Recent Developments & Business Strategy
14.1.6.Manufacturing Plant Footprint Analysis
14.2.BeumerMaschinefabrik GmbH
14.3.Crown equipment Corporation
14.4.Hyster-Yale-Materials Handling, Inc.
14.5.Hytrol Conveyor Co.
14.6.Toyota Industries Corporation
14.7.Koke Inc.
14.8.Xuzhou Heavy Machinery Co.
14.9.Viastore Systems GmbH
14.10.Jungheinrich AG
14.11.Jervish B. Webb Company
14.12.Others
